D. Giles

1.1k total citations
27 papers, 875 citations indexed

About

D. Giles is a scholar working on Organic Chemistry, Pharmacology and Molecular Biology. According to data from OpenAlex, D. Giles has authored 27 papers receiving a total of 875 indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Organic Chemistry, 5 papers in Pharmacology and 4 papers in Molecular Biology. Recurrent topics in D. Giles's work include Synthesis and biological activity (17 papers), Synthesis and Reactions of Organic Compounds (5 papers) and Synthesis and Biological Evaluation (5 papers). D. Giles is often cited by papers focused on Synthesis and biological activity (17 papers), Synthesis and Reactions of Organic Compounds (5 papers) and Synthesis and Biological Evaluation (5 papers). D. Giles collaborates with scholars based in India, United States and United Kingdom. D. Giles's co-authors include W. B. Turner, Vinod Mathew, J. Keshavayya, David C. Aldridge, V. P. Vaidya, Ekta Singh, V. Hayden Thomas, Gurubasavaraja Swamy Purawarga Matada, Amit Kumar Das and Vinod Mathew and has published in prestigious journals such as European Journal of Medicinal Chemistry, Molecular Biology Reports and Anti-Cancer Agents in Medicinal Chemistry.

In The Last Decade

D. Giles

27 papers receiving 844 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
D. Giles India 14 537 204 168 138 64 27 875
Arantxa Encinas Germany 7 347 0.6× 242 1.2× 207 1.2× 218 1.6× 82 1.3× 12 800
Dolores Vilella Spain 8 218 0.4× 344 1.7× 190 1.1× 69 0.5× 25 0.4× 8 757
M. Wagenaar United States 12 206 0.4× 197 1.0× 367 2.2× 85 0.6× 38 0.6× 15 639
Qiong‐You Wu China 16 462 0.9× 332 1.6× 60 0.4× 278 2.0× 120 1.9× 34 840
Michael Dreyer Germany 19 488 0.9× 315 1.5× 99 0.6× 184 1.3× 50 0.8× 31 979
Martina Bago Pilátová Slovakia 21 447 0.8× 704 3.5× 109 0.6× 137 1.0× 17 0.3× 71 1.2k
Subhash C. Jain India 18 632 1.2× 245 1.2× 120 0.7× 123 0.9× 19 0.3× 60 1.0k
Xiaodan Yin China 12 267 0.5× 188 0.9× 90 0.5× 200 1.4× 196 3.1× 35 733
Zhi Kai Guo China 19 213 0.4× 338 1.7× 388 2.3× 96 0.7× 25 0.4× 40 837
Ryo C. Yanagita Japan 15 205 0.4× 354 1.7× 169 1.0× 136 1.0× 21 0.3× 54 726

Countries citing papers authored by D. Giles

Since Specialization
Citations

This map shows the geographic impact of D. Giles's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by D. Giles with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites D. Giles more than expected).

Fields of papers citing papers by D. Giles

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by D. Giles. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by D. Giles. The network helps show where D. Giles may publish in the future.

Co-authorship network of co-authors of D. Giles

This figure shows the co-authorship network connecting the top 25 collaborators of D. Giles. A scholar is included among the top collaborators of D. Giles based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with D. Giles. D. Giles is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Matada, Gurubasavaraja Swamy Purawarga, et al.. (2021). Development of Fused and Substituted Pyrimidine Derivatives as Potent Anticancer Agents (A Review). Pharmaceutical Chemistry Journal. 54(12). 1215–1226. 19 indexed citations
2.
Matada, Gurubasavaraja Swamy Purawarga, et al.. (2020). Fused and Substituted Pyrimidine Derivatives as Profound Anti-Cancer Agents. Anti-Cancer Agents in Medicinal Chemistry. 21(7). 861–893. 27 indexed citations
3.
Matada, Gurubasavaraja Swamy Purawarga, et al.. (2020). Design, Synthesis, In Silico and In Vitro Evaluation of Novel Pyrimidine Derivatives as EGFR Inhibitors. Anti-Cancer Agents in Medicinal Chemistry. 21(4). 451–461. 12 indexed citations
4.
Singh, Ekta & D. Giles. (2020). Neurodegeneration by oxidative stress: a review on prospective use of small molecules for neuroprotection. Molecular Biology Reports. 47(4). 3133–3140. 59 indexed citations
5.
Giles, D., et al.. (2019). Anti-Inflammatory, Antiulcer and Anticancer Activities of Saponin Isolated from the Fruits of Ziziphus jujuba. The Natural Products Journal. 10(4). 395–399. 6 indexed citations
6.
Giles, D., et al.. (2019). Design of Chalcones of 7-Azaindole as Raf-B Inhibitors. 4(4). 606–608. 3 indexed citations
7.
Giles, D., et al.. (2018). DESIGN, SYNTHESIS AND CHEMICAL HYDROLYSIS STUDY OF CODRUGS OF METOPROLOL WITH METFORMIN. International Journal of Pharmaceutical Sciences and Drug Research. 95–102. 1 indexed citations
8.
Giles, D., et al.. (2017). Design, Synthesis and Pharmacological Evaluation of Pyrimidine Fused Indane-1,3-dione Derivatives. Der pharma chemica. 9(9). 145–151. 2 indexed citations
9.
Thomas, V. Hayden, et al.. (2017). Coumarin Derivatives as Anti-inflammatory and Anticancer Agents. Anti-Cancer Agents in Medicinal Chemistry. 17(3). 415–423. 47 indexed citations
10.
Giles, D., et al.. (2015). DESIGN OF COX-2 INHIBITORS–AN IN-SILICO APPROACH. 7(9). 46–50. 1 indexed citations
11.
Giles, D., et al.. (2012). Synthesis pharmacological evaluation and docking studies of pyrimidine derivatives. European Journal of Medicinal Chemistry. 58. 478–484. 58 indexed citations
12.
Giles, D., et al.. (2011). Synthesis and Pharmacological evaluation of Schiff's and Mannich bases of Indole Derivatives. 1(1). 2 indexed citations
13.
Giles, D., et al.. (2011). Synthesis, pharmacological evaluation and docking studies of coumarin derivatives. European Journal of Medicinal Chemistry. 46(9). 4696–4701. 39 indexed citations
14.
Mathew, Vinod, et al.. (2007). Studies on synthesis and pharmacological activities of 3,6-disubstituted-1,2,4-triazolo[3,4-b]-1,3,4-thiadiazoles and their dihydro analogues. European Journal of Medicinal Chemistry. 42(6). 823–840. 134 indexed citations
15.
Mathew, Vinod, J. Keshavayya, V. P. Vaidya, & D. Giles. (2007). Studies on Synthesis and Pharmacological Activities of 3,6‐Disubstituted‐1,2,4‐triazolo[3,4‐b]‐1,3,4‐thiadiazoles and Their Dihydro Analogues.. ChemInform. 38(42). 121 indexed citations
16.
Meena, Sher Singh, et al.. (2006). Synthesis of 2-(aryl methylene)-(1 H )- indane- 1, 3-(2 H )-diones as potential fungicidal and bactericidal agents. Indian Journal of Chemistry Section B-organic Chemistry Including Medicinal Chemistry. 45(6). 1572–1575. 2 indexed citations
17.
18.
Aldridge, David C., D. Giles, & W. B. Turner. (1970). Antibiotic 1233A: a fungal β-lactone. Journal of the Chemical Society D Chemical Communications. 0(11). 639–639. 9 indexed citations
19.
Giles, D. & W. B. Turner. (1969). Chlorine-containing metabolites of Periconia macrospinosa. Journal of the Chemical Society C Organic. 16(16). 2187–2187. 20 indexed citations
20.
Giles, D., et al.. (1966). Some iodinated pyrazole derivatives. Journal of the Chemical Society C Organic. 13. 1179–1179. 15 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026